Searchable abstracts of presentations at key conferences in endocrinology

ea0056p321 | Clinical case reports - Thyroid/Others | ECE2018

Effect of hemoglobin J variant on HbA1c values as measured by HPLC (high-perfomance liquid chromatography)

Ares Blanco Jessica , Bernardo Gutierrez Angel , Martin-Nieto Alicia , Gonzalez-Martinez Silvia , Delgado-Alvarez Elias , Menendez-Torre Edelmiro

Hemoglobin A1c (HbA1c) is used for the long-term management of patients with diabetes mellitus (DM). Hemoglobin variants other than HbA1c and e-N-lysine-glycated HbA0 may cause analytical interference in determinations of HbA1c. Hemoglobin J is an abnormal hemoglobin, an alpha globin gene variant and present in various geographic locations. Hemoglobin J (depending on its type) has different characteristics and functions. For example hemoglobin J Capetown (α2 92Gln β2...

ea0081p386 | Endocrine-Related Cancer | ECE2022

Urinary steroid metabolomics for adrenocortical cancer diagnosis. Comparison of gas chromatography mass spectrometry to liquid chromatography mass spectrometry

Taylor Angela , Bancos Irina , Gilligan Lorna , van Veen Rick , Chortis Vasileios , Shaheen Fozia , Jenkinson Carl , O'Neil Donna M , Hughes Beverly , Hawley James M , Keevil Brian , Shackelton Cedric H L , Deeks Jonathan , Sitch Alice J , Biehl Michael , Arlt Wiebke

Introduction: Gas chromatography mass spectrometry (GC-MS) is the gold standard method for urinary steroid profiling. However, GC-MS requires chemical derivatisation, long run times, is labour intensive, expensive, and unsuitable for rapid multi-sample analysis, limiting its use in routine clinical practice. GC-MS urinary steroid metabolomics, the combination of steroid profiling and machine learning (Generalized Matrix Learning Vector Quantization) was shown to have superior ...

ea0090p761 | Thyroid | ECE2023

J – 131 therapy of autonomously functioning thyroid adenoma: the outcome of our 20 – years experience

Petrovski Zlatko

Objective: To investigate the results of J – 131 treatments in patients (pts) with autonomous thyroid adenomas in long period of follow up.Material and Methods: We enrolled 68 consecutive pts with Plummer’s disease (50 females, 18 males, mean age 54,7 yrs, range 21 – 79 yrs) for period 2000 – 2020 yrs. 87%(59/68) pts had a unifocal nodule, while 13% (9/68) pts had multifocal toxic autonomous nodules. Pts stopped antithyroid drugs for ...

ea0090oc11.2 | Oral Communications 11: Late Breaking | ECE2023

Machine learning-based steroid metabolome analysis reveals three distinct subtypes of polycystic ovary syndrome and implicates 11-oxygenated androgens as major drivers of metabolic risk

Melson Eka , Rocha Thais P. , Veen Roland J. , Abdi Lida , Mcdonnell Tara , Tandl Veronika , Hawley James M. , Wittemans Laura B.L. , Anthony Amarah V. , Gilligan Lorna C. , Shaheen Fozia , Kempegowda Punith , Gillett Caroline D.T , Cussen Leanne , Missbrenner Cornelia , Lajeunesse-Trempe Fannie , Gleeson Helena , Aled Rees D. , Robinson Lynne , Jayasena Channa , Randeva Harpal S. , Dimitriadis Georgios K. , Gomes Larissa , Sitch Alice J. , Vradi Eleni , Taylor Angela E. , O'Reilly Michael W. , Obermayer-Pietsch Barbara , Biehl Michael , Arlt Wiebke

Introduction: Polycystic ovary syndrome affects 10% of women and comes with a 2-3fold increased risk of type 2 diabetes, hypertension, and fatty liver disease. Androgen excess, a cardinal feature of PCOS, has been implicated as a major contributor to metabolic risk. Adrenal-derived 11-oxygenated androgens represent an important component of PCOS-related androgen excess and are preferentially activated in adipose tissue. We aimed to identify PCOS sub-types with distinct androge...

ea0094oc4.1 | Reproductive Endocrinology | SFEBES2023

Unsupervised steroid metabolome cluster analysis to dissect androgen excess and metabolic dysfunction in 488 women with polycystic ovary syndrome – results from the prospective DAISy-PCOS study

Melson Eka , Rocha Thais P. , Veen Roland J. , Abdi Lida , McDonnell Tara , Tandl Veronika , Hawley James M. , Wittemans Laura B. L. , Anthony Amarah V. , Gilligan Lorna C. , Shaheen Fozia , Kempegowda Punith , Gillett Caroline D.T. , Cussen Leanne , Missbrenner Cornelia , Lajeunesse-Trempe Fannie , Gleeson Helena , Rees Aled , Robinson Lynne , Jayasena Channa , Randeva Harpal S. , Dimitriadis Georgios K. , Gomes Larissa G. , J. Sitch Alice , Vradi Eleni , Obermayer-Pietsch Barbara , O'Reilly Michael W. , Taylor Angela E. , Biehl Michael , Arlt Wiebke

Introduction: Polycystic ovary syndrome (PCOS) affects 10% of women and is associated with a 2-3fold risk of type 2 diabetes (T2D), hypertension, fatty liver and cardiovascular disease. Androgen excess has been implicated as a major contributor to metabolic risk in PCOS. We aimed to identify PCOS sub-types with distinct androgen profiles and compare their cardiometabolic risk.Methods: We cross-sectionally studied 488 tre...

ea0099rc11.4 | Rapid Communications 11: Adrenal and Cardiovascular Endocrinology | Part II | ECE2024

Urine steroid metabolomics to diagnose endocrine hypertension: results from the ENS@T-HT project

Prete Alessandro , Abdi Lida , Suntornlohanakul Onnicha , Lang Katharina , Veen Roland , Canducci Marco , Riancho Julien , Lazkani Aida , Larsen Casper K. , Gimenez-Roqueplo Anne-Paule , Pecori Alessio , Tetti Martina , Monticone Silvia , Muller Lisa M. , Adolf Christian , Timmers Henri JLM , Hampson Stephanie , Eisenhofer Graeme , Ceccato Filippo , Beuschlein Felix , Kabat Marek , Bertherat Jerome , Dennedy M. Conall , Davies Eleanor , Deinum Jaap , Reincke Martin , Rossi Gian Paolo , Mulatero Paolo , Amar Laurence , Zennaro Maria-Christina , Sitch Alice J. , Tino Peter , Biehl Michael , Taylor Angela E. , Arlt Wiebke

Background: Hypertension affects more than 30% of the adult population worldwide and is a major cardiovascular risk factor. Identifying secondary causes of hypertension is key to offering targeted treatments and mitigating adverse health outcomes. We tested the performance of urine steroid metabolomics (USM), the computational analysis of 24-hour urine steroid metabolome data by machine learning, for diagnosing endocrine forms of hypertension.Methods: 14...

ea0025pl3biog | Society for Endocrinology Transatlantic Medal Lecture | SFEBES2011

Society for Endocrinology Transatlantic Medal Lecture

Kopchick J J

J J Kopchick, Ohio University, Athens, Ohio, USA. AbstractDr John J Kopchick is an internationally recognized leader in the growth hormone (GH) field. Since 1987, he has held the Milton and Lawrence H Goll Eminent Scholar Professorship in Molecular and Cellular Biology and directs the Growth/Obesity/Diabetes Section of the Edison Biotechnology Institute at Ohio University in Athens, Ohio. He also is Professor in the B...

ea0086p205 | Metabolism, Obesity and Diabetes | SFEBES2022

UCP1 expression in human brown adipose tissue is inversely associated with cardiometabolic risk factors

Choong Kwok T'ng , E Ramage Lynne , Kelman Alexandra , Wakelin Sonia J , Stimson Roland H

Introduction: Brown adipose tissue (BAT) increases energy expenditure and is a potential therapeutic target for obesity and associated cardiometabolic disease. It is unclear whether human BAT activity is reduced in obesity, as BAT 18F-fluorodeoxyglucose uptake is reduced but BAT metabolic activity measured using11C-acetate PET is preserved. BAT thermogenesis relies on the presence of uncoupling protein 1 (UCP1), which uncouples oxidative phosphorylation f...

ea0077pl2 | Society for Endocrinology Starling Medal Lecture | SFEBES2021

Strategies to turn up the heat – investigating human brown adipose tissue function

Stimson Roland

The obesity epidemic has underlined the need for new treatments to aid weight loss and prevent the associated sequelae of obesity such as type 2 diabetes, hypertension, dyslipidaemia and cardiovascular disease. The relatively recent discovery of brown adipose tissue (BAT) in adult humans has revived interest in activating this tissue to increase energy expenditure as a novel treatment for obesity and associated metabolic disease. BAT is a thermogenic organ that generates heat ...

ea0081ap1 | The European Journal of Endocrinology Award Lecture | ECE2022

The regulation of human brown adipose tissue

Stimson Roland

The obesity epidemic has underlined the need for new treatments to aid weight loss and prevent the associated cardiometabolic sequelae of obesity. The relatively recent discovery of brown adipose tissue (BAT) in adult humans has revived interest in activating this tissue to increase energy expenditure as a novel treatment for these conditions. BAT is a thermogenic organ that generates heat to maintain body temperature in a cold environment. While BAT mass and activity are redu...